This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

16 Mar 2011

Overseas Manufacturing Puts U.S. at Risk

More drugs approved in the U.S. are manufactured overseas. This makes FDA inspection rate drop.

FDA is having a hard time keeping up with inspections in the supply chain as many of the drugs approved in the U.S. are now manufactured overseas. The result could be another tainted-drug disaster just waiting to happen. This is not an FDA watchdog with an agenda sounding the alarm; the agency itself came out with the dire warning.


"The safety of America's food and medical products is under serious challenge," warned senior FDA official John Taylor, who was speaking at a Pew Health Group meeting. He raised the specter of "another public health crisis like Heparin." In 2008, contaminants in the blood thinner Heparin produced in China led t

Related News